South Asian Heart Health Awareness and Research Act of 2023

Healthcare: US Senate, US House, FDA, HHS, CMS, OMB, NIH, White House Office/AHRQ Health care quality; physician and hospital quality; health care innovation; Patient Protection and Affordable Care Act/health care reform implementation; unique device identifier policy and post-market surveillance for medical devices; clinical trial design; HIPAA and registries; federal funding/appropriations for HHS, NIH, AHRQ, CDC, FDA, HRSA and the Childrens Hospital Graduate Medical Education payment program, the Prevention & Public Health Fund, medical research, and prevention; research and scholarly communication policy; implementation and oversight of 21st Century Cures Act; data blocking/interoperability of electronic data; artificial intelligence/machine learning; algorithm transparency; health disparities; reduction/oversight of prior authorization and other administrative burdens; digital health; Sect. 1557 Nondiscrimination in Health Programs and Activities; cardiomyopathy education and awareness; peripheral arterial disease (PAD) education and awareness; VA Mission Act implementation; COVID-19 and implementation of the Coronavirus Preparedness and Response Supplemental Appropriations Act, the Families First Coronavirus Response Act , the Coronavirus Aid, Relief, and Economic Security Act, Coronavirus Provider Protection Act, and clinician mental health and wellbeing; patient identification; Pandemic and All Hazards Preparedness; MCIT/TCET/Breakthrough devices; Heart Health Enhancement through Access to Research and Training (HEART) Act (H.R. 880); Safety from Violence for Healthcare Employees (SAVE) Act (H.R. 2584/S. 2768); Workplace Violence Prevention for Health Care and Social Service Worker Act (H.R. 2663/S.1176); the Access to AEDs Act (H.R. 2370/S. 1024); Amputation Reduction and Compassion (ARC) Act (H.R. 4261); Resident Education Deferred Interest (REDI) Act (H.R. 1202) South Asian Heart Health Awareness and Research Act (H.R. 4914); Lower Costs More Transparency Act (H.R. 5378); Cardiomyopathy Health, Education, Awareness, Research and Training in Schools (HEARTS) Act (H.R. 6829); No Fees for EFTs Act (H.R. 6487/S. 3805); Dr. Lorna Breen Health Care Provider Protection Reauthorization Act (H.R. 7153/S. 3679); Congenital Heart Futures Reauthorization Act (H.R. 7189); Health Care PRICE Transparency Act 2.0 (S. 3548); Physician Led and Rural Access to Access to Quality Care Act (H.R. 9001)

Client expense: $410,000 · Firm income: Not reported

Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, White House Office

Healthcare: US Senate, US House, FDA, HHS, CMS, OMB, NIH, White House Office/AHRQ Health care quality; physician and hospital quality; health care innovation; Patient Protection and Affordable Care Act/health care reform implementation; unique device identifier policy and post-market surveillance for medical devices; clinical trial design; HIPAA and registries; federal funding/appropriations for HHS, NIH, AHRQ, CDC, FDA, HRSA and the Childrens Hospital Graduate Medical Education payment program, the Prevention & Public Health Fund, medical research, and prevention; research and scholarly communication policy; implementation and oversight of 21st Century Cures Act; data blocking/interoperability of electronic data; artificial intelligence/machine learning; algorithm transparency; health disparities; reduction/oversight of prior authorization and other administrative burdens; digital health; Sect. 1557 Nondiscrimination in Health Programs and Activities; cardiomyopathy education and awareness; peripheral arterial disease (PAD) education and awareness; VA Mission Act implementation; COVID-19 and implementation of the Coronavirus Preparedness and Response Supplemental Appropriations Act, the Families First Coronavirus Response Act , the Coronavirus Aid, Relief, and Economic Security Act, Coronavirus Provider Protection Act, and clinician mental health and wellbeing; patient identification; Pandemic and All Hazards Preparedness; MCIT/TCET/Breakthrough devices; Heart Health Enhancement through Access to Research and Training (HEART) Act (H.R. 880); Safety from Violence for Healthcare Employees (SAVE) Act (H.R. 2584/S. 2768); Workplace Violence Prevention for Health Care and Social Service Worker Act (H.R. 2663/S.1176); the Access to AEDs Act (H.R. 2370/S. 1024); Amputation Reduction and Compassion (ARC) Act (H.R. 4261); Resident Education Deferred Interest (REDI) Act (H.R. 1202) South Asian Heart Health Awareness and Research Act (H.R. 4914); Lower Costs More Transparency Act (H.R. 5378); Cardiomyopathy Health, Education, Awareness, Research and Training in Schools (HEARTS) Act (H.R. 6829); No Fees for EFTs Act (H.R. 6487/S. 3805); Dr. Lorna Breen Health Care Provider Protection Reauthorization Act (H.R. 7153/S. 3679); Congenital Heart Futures Reauthorization Act (H.R. 7189); Health Care PRICE Transparency Act 2.0 (S. 3548)

Client expense: $440,000 · Firm income: Not reported

Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, White House Office

Healthcare: US Senate, US House, FDA, HHS, CMS, OMB, NIH, White House Office/AHRQ Health care quality; physician and hospital quality; health care innovation; Patient Protection and Affordable Care Act/health care reform implementation; unique device identifier policy and post-market surveillance for medical devices; clinical trial design; HIPAA and registries; federal funding/appropriations for HHS, NIH, AHRQ, CDC, FDA, HRSA and the Childrens Hospital Graduate Medical Education payment program, the Prevention & Public Health Fund, medical research, and prevention; research and scholarly communication policy; implementation and oversight of 21st Century Cures Act; data blocking/interoperability of electronic data; artificial intelligence/machine learning; algorithm transparency; health disparities; reduction/oversight of prior authorization and other administrative burdens; digital health; Sect. 1557 Nondiscrimination in Health Programs and Activities; cardiomyopathy education and awareness; peripheral arterial disease (PAD) education and awareness; VA Mission Act implementation; COVID-19 and implementation of the Coronavirus Preparedness and Response Supplemental Appropriations Act, the Families First Coronavirus Response Act , the Coronavirus Aid, Relief, and Economic Security Act, Coronavirus Provider Protection Act, and clinician mental health and wellbeing; patient identification; Pandemic and All Hazards Preparedness; Heart Health Enhancement through Access to Research and Training (HEART) Act (H.R. 880); Safety from Violence for Healthcare Employees (SAVE) Act (H.R. 2584/S. 2768); Workplace Violence Prevention for Health Care and Social Service Worker Act (H.R. 2663/S.1176); the Access to AEDs Act (H.R. 2370/S. 1024); Amputation Reduction and Compassion (ARC) Act (H.R. 4261); Resident Education Deferred Interest (REDI) Act (H.R. 1202) South Asian Heart Health Awareness and Research Act (H.R. 4914); Lower Costs More Transparency Act (H.R. 5378); Cardiomyopathy Health, Education, Awareness, Research and Training in Schools (HEARTS) Act (H.R. 6829); No Fees for EFTs Act (H.R. 6487/S. 3805); Dr. Lorna Breen Health Care Provider Protection Reauthorization Act (H.R. 7153/S. 3679); Congenital Heart Futures Reauthorization Act (H.R. 7189); Health Care PRICE Transparency Act 2.0 (S. 3548)

Client expense: $530,000 · Firm income: Not reported

Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, White House Office